Cargando…

MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. However, stage IV ccRCC is generally incurable and its molecular mechanism has not yet been fully clarified. In this study, in order to screen differentially expressed genes (DEGs) between stage IV and stage I ccRCC sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Han, Wei, Pengtao, Lv, Wenwei, Han, Xingtao, Yang, Jinhui, Qin, Shuaifeng, Zhang, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016465/ https://www.ncbi.nlm.nih.gov/pubmed/31813279 http://dx.doi.org/10.1177/0963689719890860

Ejemplares similares

Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression
por: Zhang, Han, et al.
Publicado: (2019)

PRAS40 signaling in tumor
por: Lv, Dan, et al.
Publicado: (2017)

High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
por: Zhou, Jintuo, et al.
Publicado: (2020)

PRAS40 hyperexpression promotes hepatocarcinogenesis
por: Qi, Zhaolai, et al.
Publicado: (2020)

PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40
por: Zhang, Tianhua, et al.
Publicado: (2022)

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

Effect of PI3K/Akt Signaling Pathway on PRAS40Thr246 Phosphorylation in Gastric Cancer Cells
por: LU, Yizhuo, et al.
Publicado: (2019)

TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner
por: Shen, Wenzhi, et al.
Publicado: (2022)

Knockdown of Serine–Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells
por: Han, Xingtao, et al.
Publicado: (2017)

Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells
por: Chen, Kun, et al.
Publicado: (2019)

The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma
por: Chen, Gang, et al.
Publicado: (2021)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Prognostic role of phospho-PRAS40 (Thr246) expression in gastric cancer
por: Lu, Yi-Zhuo, et al.
Publicado: (2013)

Structural Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
por: Yang, Haijuan, et al.
Publicado: (2017)

Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
por: Basu, Aninda, et al.
Publicado: (2011)

Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
por: Qi, Zhaolai, et al.
Publicado: (2020)

PRAS40 promotes NF-κB transcriptional activity through association with p65
por: Zhu, G, et al.
Publicado: (2017)

PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity
por: Völkers, Mirko, et al.
Publicado: (2014)

Phosphorylation of PRAS40 contributes to the activation of the PI3K/AKT/mTOR signaling pathway and the inhibition of autophagy following status epilepticus in rats
por: Lin, Junyi, et al.
Publicado: (2020)

PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells
por: Zhang, Kevin Sun, et al.
Publicado: (2019)

PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis
por: Thedieck, Kathrin, et al.
Publicado: (2007)

Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats
por: Cao, Yunshan, et al.
Publicado: (2017)

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018)

Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis
por: Takeuchi, Hiroaki, et al.
Publicado: (2017)

Phospho-PRAS40(Thr246) predicts trastuzumab response in patients with HER2-positive metastatic breast cancer
por: YUAN, KAI, et al.
Publicado: (2015)

Aescin Protects Neuron from Ischemia-Reperfusion Injury via Regulating the PRAS40/mTOR Signaling Pathway
por: Gao, Xinjie, et al.
Publicado: (2020)

TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
por: Xie, Yingbin, et al.
Publicado: (2020)

PTEN inhibitor VO-OHpic suppresses TSC2(-)(/)(-) MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathway
por: Wang, Wenda, et al.
Publicado: (2020)

P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
por: Bian, Shu, et al.
Publicado: (2013)

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
por: Oudaert, Inge, et al.
Publicado: (2022)

p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
por: Zhao, Jianlan, et al.
Publicado: (2021)

Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis
por: Cui, Yuanshan, et al.
Publicado: (2021)

Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
por: Li, Xiaohui, et al.
Publicado: (2020)

Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14
por: Sanjurjo, Lucía, et al.
Publicado: (2023)

Identification of key genes involved in the metastasis of clear cell renal cell carcinoma
por: Wei, Wenhao, et al.
Publicado: (2019)

Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma
por: Du, Yiqing, et al.
Publicado: (2017)

MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma
por: Shi, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c1vm8r9neklhqfln17gk7s41dc